Beam Therapeutics jumps 22% after outlining 2026 pipeline goals, including accelerated approval plans for BEAM-302 and a ...
We currently know that COPD, and specifically emphysema, is not just a lung disease found alongside lung cancer; it increases ...
A new study led by researchers at National Jewish Health provides quantitative evidence linking burn pit smoke exposure during military deployment to increases in harmful carbon-based particles in the ...
Tessera Therapeutics, the biotechnology company pioneering a new approach in genetic medicine known as Gene Writing™, today announced that the U.S. Food and Drug Administration (FDA) has cleared its ...
News-Medical.Net on MSN
Burn pit smoke exposure leaves lasting carbon particles in veterans’ lungs
A new study led by researchers at National Jewish Health provides quantitative evidence linking burn pit smoke exposure ...
A new study led by researchers at National Jewish Health provides quantitative evidence linking burn pit smoke exposure during military deployment to ...
Estimated YUTREPIA™ net product sales of approximately $90.1 million in the fourth quarter and $148.3 million for full-year ...
Estimated YUTREPIA net product sales of approximately $90.1 million in the fourth quarter and $148.3 million for full-year 2025Received more than 2,800 unique patient prescriptions since launch in Jun ...
The National Testing Agency (NTA) has issued the subject wise NEET 2026 syllabus on this website soon after the NMC released ...
GSK has received approval from China’s National Medical Products Administration for Nucala as an add-on maintenance therapy for adults with inadequately controlled COPD and elevated blood eosinophils.
A new wellness centre has opened its doors in Clydebank, offering oxygen therapy designed to support recovery and improve ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback